Low-level stress induces production of neuroprotective factors in wild-type but not BDNF+/- mice: Interleukin-10 and kynurenic acid

International Journal of Neuropsychopharmacology

Volumn 19, Issue 3, 2015, Pages 1-5

  Dugan, Allison M ^a   Parrott, Jennifer M ^a   Redus, Laney ^a   Hensler, Julie G ^a   O'Connor, Jason C ^a,b  

^a University of Texas Health Science Center   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Kynurenine; neuroinflammation; vulnerability

Indexed keywords

3 HYDROXYKYNURENINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; INTERLEUKIN 10; KYNURENIC ACID; KYNURENINE; IL10 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; MALE; METABOLISM; METABOLITE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS; WILD TYPE; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; MENTAL STRESS; PHYSIOLOGY; TRANSGENIC MOUSE; UNCERTAINTY;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; INTERLEUKIN-10; KYNURENIC ACID; KYNURENINE; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUROIMMUNOMODULATION; STRESS, PSYCHOLOGICAL; UNCERTAINTY;

EID: 84963959985     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyv089     Document Type: Article

References (27)

1. Advani T, Koek W, Hensler JG (2009) Gender differences in the enhanced vulnerability of BDNF+/-mice to mild stress. Int J Neuropsychopharmacol 12:583-588.
2. Altar CA (1999) Neurotrophins and depression. Trends Pharmacol Sci 20: 59-61.
3. Burke TF, Advani T, Adachi M, Monteggia LM, Hensler JG (2013) Sensitivity of hippocampal serotonin1A receptors to stress in mice deficient in brain-derived neurotrophic factor. Int J Neuropsychopharm 16:631-645.
4. Calabrese F, Molteni R, Racagni G, Riva MA (2009) Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 34 [Suppl 1]:S208-S216.
5. Capuron L, Miller AH (2011) Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther. 130:226-238.
6. Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, Hempstead BL, Lee FS (2004) Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci. 24:4401-4411.
7. Chourbaji S, Hellweg R, Brandis D, Zorner B, Zacher C, Lang UE, Henn FA, Hortnagl H, Gass P (2004) Mice with reduced brainderived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res Mol Brain Res. 121:28-36.
8. Deak T, Bordner KA, McElderry NK, Barnum CJ, Blandino P Jr, Deak MM, Tammariello SP (2005) Stress-induced increases in hypothalamic IL-1: a systematic analysis of multiple stressor paradigms. Brain Res Bull 64:541-556.
9. Duman CH, Schlesinger L, Kodama M, Russell DS, Duman RS (2007) A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry 61:661-670.
10. Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116-1127.
11. Egan MF, Kojima M, Callicott JH, Goldberg TE, Koachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257-269.
12. Guillemin GJ, Kerr SJ, Smythe GA, Smith DG, Kapoor V, Armati PJ, Croitoru, J Brew BJ (2001) Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J Neurochem 78:842-853.
13. Heisler JM, O'Connor JC (2015) Indoleamine 2,3-dioxygenasedependent neurotoxic kynurenine metabolism mediates inflammation induced deficit in recognition memory. Brain Behav Immun June 27 Epub. doi: 10.1016/j.bbi.2015.06.022.
14. Henry CJ, Huang Y, Wynne AM, Godbout JP (2009) Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and antiinflammatory IL-10 cytokines. Brain Behav Immun 23:309-317.
15. Hosang GM1, Shiles C, Tansey KE, McGuffin P, Uher R (2014) Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis. BMC Med 2014 12:7.
16. Lawson MA, Parrott JM, McCusker RH, Dantzer R, Kelley KW, O'Connor JC (2013) Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors. J Neuroinflammation 10:87.
17. Ledeboer A, Breve JJ, Wierinckx A, van der Jagt S, Bristow AF, Leysen JE, Tilders FJ, Van Dam AM (2002) Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells. Eur J Neurosci 16:1175-1185.
18. Norden D M, Fenn AM, Dugan A, Godbout JP (2014) TGFbeta produced by IL-10 redirected astrocytes attenuates microglial activation. Glia 62:881-895.
19. O'Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, Kelley KW, Dantzer R (2009). Lipopolysaccharideinduced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14:511-522.
20. Parrott JM, Redus L, O'Connor JC (2012) Brain-derived neurotrophic factor deficient mice exhibit vulnerability to lipopolysaccharide-induced neuropsychiatric-like behaviors. Program No. 660.13/R7. Society for Neuroscience, 2012.
21. Patki G, Solanki N, Atrooz F, Allam F, Salim S (2013) Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress. Brain Res 1539:73-86.
22. Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27:24-31.
23. Salazar A, Gonzalez-Rivera BL, Redus L, Parrott JM, O'Connor JC (2012) Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Horm Behav 62:202-209.
24. Schwarcz R, Pellicciari R (2002) Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303:1-10.
25. Walker AK, Budac DP, Bisulco S, Lee AW, Smith RA, Beenders, B, Kelley KW, Dantzer R (2013) NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressivelike behavior in C57BL/6J mice. Neuropsychopharmacology 38:1609-1616.
26. Wohleb ES, Hanke ML, Corona AW, Powell ND, Stiner LM, Bailey MT, Nelson RJ, Godbout JP, Sheridan JF (2011) β-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J Neurosci 3:6277-6288.
27. Yu H, Wang DD, Wang Y, Liu T, Lee FS, Chen ZY (2012) Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants. J Neurosci 32:4092-4101.